GlassScriptPhysician profile
Rohit B Shahani
NPI 1003851379
$8,598.64
in general payments reported to CMS, 2019-2025
24 companies · $1,308 in 2025
The $1,308 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,802 · 2020: $688 · 2021: $367 · 2022: $607 · 2023: $1,088 · 2024: $1,738 · 2025: $1,308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,692 · Travel and Lodging: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,691.97 |
| Travel and Lodging | $442.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,931.47 | 2019-2025 | Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia, Inspiris Resilia Aortic Valve |
| Abiomed | $776.24 | 2021-2025 | Impella |
| Medtronic, INC. | $714.29 | 2022-2025 | Corevalve Evolut R, Aurora Ev-Icd Mri Surescan |
| Medistim USA, INC. | $607.92 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $558.29 | 2023-2025 | A&E Medical / Sternalock Xp Rigid Fixation System, Sternalock Blu System |
| Abbott Laboratories | $551.55 | 2019-2025 | Mitraclip, Aveir |
| Atricure, INC. | $286.40 | 2022-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Becton, Dickinson and Company | $216.56 | 2025 | Hemosphere |
| Baxter Healthcare | $124.62 | 2019 | |
| Janssen Pharmaceuticals, INC | $104.53 | 2019 | |
| Boston Scientific Corporation | $97.20 | 2019 | |
| Livanova USA, INC. | $95.86 | 2019 | |
| Teleflex LLC | $92.34 | 2023 | Manta |
| Amgen INC. | $91.50 | 2019-2020 | |
| Philips North America LLC | $84.85 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $82.39 | 2019-2020 | |
| Akcea Therapeutics, INC. | $53.03 | 2020 | |
| Janssen Biotech, INC. | $24.06 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $21.81 | 2019 | |
| Astellas Pharma US INC | $18.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.50 | 2025 | Tagrisso |
| Amarin Pharma, INC. | $16.95 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.38 | 2020 | |
| La Jolla Pharmaceutical Company | $14.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Shahani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.